CaSiO3 microstructure modulating the in vitro and in vivo bioactivity of poly(lactide-co-glycolide) microspheres

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 1, 2011, Pages 122-131

  Wu, Chengtie ^a   Zhang, Yufeng ^a,b   Fan, Wei ^a   Ke, Xuebin ^a   Hu, Xuye ^a   Zhou, Yinghong ^a   Xiao, Yin ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b WUHAN UNIVERSITY   (China)

Author keywords

amorphous; bioactivity; CaSiO3 phase structure; crystal

Indexed keywords

ADSORPTION DESORPTION; BONE REGENERATION; BONE REPAIR; BONE TISSUE; BONE TISSUE REGENERATION; CASIO3 PHASE STRUCTURE; COMPOSITE MICROSPHERES; HUMAN BONES; IN-VITRO; IN-VITRO BIOACTIVITY; IN-VIVO; MESENCHYMAL STEM CELL; PLGA MICROSPHERES; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; POLY-LACTIDE-CO-GLYCOLIDE; POLYMER MICROSPHERES; REGENERATIVE MEDICINE; SIMULATED BODY FLUIDS; SURFACE AREA;

ADSORPTION; BIOACTIVITY; BIOCOMPATIBILITY; BONE; CELL CULTURE; CRYSTAL MICROSTRUCTURE; DESORPTION; DRUG DELIVERY; INVESTMENTS; PHASE STRUCTURE; PHOSPHATE MINERALS; SCANNING ELECTRON MICROSCOPY; STEM CELLS; SURFACE STRUCTURE; TISSUE; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

MICROSPHERES;

CALCIUM SILICATE; POLYGLACTIN; BIOMATERIAL; CALCIUM DERIVATIVE; LACTIC ACID; MICROSPHERE; MINERAL; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SILICATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FLUID; BONE MARROW CELL; BONE REGENERATION; CELL VIABILITY; CHEMICAL STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; ADSORPTION; ANIMAL; BONE; BONE DEVELOPMENT; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; MICRO-COMPUTED TOMOGRAPHY; MOUSE MUTANT; PH; POROSITY; POWDER; RADIOGRAPHY; SOLUTION AND SOLUBILITY; TEMPERATURE;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MARROW CELLS; CALCIUM COMPOUNDS; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MINERALS; OSTEOGENESIS; POLYGLYCOLIC ACID; POROSITY; POWDERS; SILICATES; SOLUTIONS; TEMPERATURE; X-RAY DIFFRACTION; X-RAY MICROTOMOGRAPHY;

EID: 79958224707     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33092     Document Type: Article

References (38)

1. Zhu XH, Wang CH, Tong YW,. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A 2009; 89: 411-423.
2. Hori Y, Winans AM, Irvine DJ,. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater 2009; 5: 969-982.
3. Barrias CC, Ribeiro CC, Lamghari M, Miranda CS, Barbosa MA,. Proliferation, activity, and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres. J Biomed Mater Res A 2005; 72: 57-66. (Pubitemid 39642230)
4. Wu C, Zreiqat H,. Porous bioactive diopside (CaMgSi(2)O(6)) ceramic microspheres for drug delivery. Acta Biomater 2010; 6: 820-829.
5. Wu C, Zhu Y, Chang J, Zhang Y, Xiao Y,. Bioactive inorganic-materials/ alginate composite microspheres with controllable drug-delivery ability. J Biomed Mater Res B Appl Biomater 2010; 94: 32-43.
6. Mateus AY, Barrias CC, Ribeiro C, Ferraz MP, Monteiro FJ,. Comparative study of nanohydroxyapatite microspheres for medical applications. J Biomed Mater Res A 2008; 86: 483-493. (Pubitemid 351969647)
7. Jongpaiboonkit L, Frankilin-Ford T, Murphy W,. Mineral-coated polymer microspheres for controlled protein binding and release. Adv Mater 2009; 21: 1-4.
8. Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y,. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 2009; 30: 1947-1953.
9. Tabata Y,. Biomaterial technology for tissue engineering applications. J R Soc Interface 2009; 6 (Suppl 3): S311-S324.
10. Bertoldi C, Zaffe D, Consolo U,. Polylactide/polyglycolide copolymer in bone defect healing in humans. Biomaterials 2008; 29: 1817-1823.
11. Zhang P, Hong Z, Yu T, Chen X, Jing X,. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(L -lactide). Biomaterials 2009; 30: 58-70.
12. Hong Z, Zhang P, He C, Qiu X, Liu A, Chen L, Chen X, Jing X,. Nano-composite of poly(L -lactide) and surface grafted hydroxyapatite: Mechanical properties and biocompatibility. Biomaterials 2005; 26: 6296-6304. (Pubitemid 40828385)
13. Kang SW, Yang HS, Seo SW, Han DK, Kim BS,. Apatite-coated poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for bone tissue engineering. J Biomed Mater Res A 2008; 85: 747-756. (Pubitemid 351632888)
14. Jevtic M, Radulovic A, Ignjatovic N, Mitric M, Uskokovic D,. Controlled assembly of poly(D,L -lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation. Acta Biomater 2009; 5: 208-218.
15. Ni S, Chang J, Chou L,. A novel bioactive porous CaSiO3 scaffold for bone tissue engineering. J Biomed Mater Res A 2006; 76: 196-205. (Pubitemid 43075697)
16. Xue W, Liu X, Zheng X, Ding C,. In vivo evaluation of plasma-sprayed wollastonite coating. Biomaterials 2005; 26: 3455-3460. (Pubitemid 40038139)
17. Liu X, Ding C, Wang Z,. Apatite formed on the surface of plasma-sprayed wollastonite coating immersed in simulated body fluid. Biomaterials 2001; 22: 2007-2012. (Pubitemid 32567637)
18. Xu S, Lin K, Wang Z, Chang J, Wang L, Lu J, Ning C,. Reconstruction of calvarial defect of rabbits using porous calcium silicate bioactive ceramics. Biomaterials 2008; 29: 2588-2596.
19. Li H, Zhai W, Chang J,. In vitro biocompatibility assessment of PHBV/Wollastonite composites. J Mater Sci Mater Med 2008; 19: 67-73.
20. Li H, Chang J,. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds. Biomaterials 2004; 25: 5473-5480. (Pubitemid 38610185)
21. Li H, Chang J,. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. J Control Release 2005; 107: 463-473. (Pubitemid 41393355)
22. Li X, Chang J,. Preparation and characterization of bioactive collagen/wollastonite composite scaffolds. J Mater Sci Mater Med 2005; 16: 361-365. (Pubitemid 40558517)
23. Wu C, Ramaswamy Y, Zhu Y, Zheng R, Appleyard R, Howard A, Zreiqat H,. The effect of mesoporous bioactive glass on the physiochemical, biological and drug-release properties of poly(DL -lactide-co-glycolide) films. Biomaterials 2009; 30: 2199-2208.
24. Wu C, Zhang Y, Zhu Y, Friis T, Xiao Y,. Structure-property relationships of silk-modified mesoporous bioglass scaffolds. Biomaterials 2010; 31: 3429-3438.
25. Zhang Y, Wu C, Friis T, Xiao Y,. The osteogenic properties of CaP/silk composite scaffolds. Biomaterials 2010; 31: 2848-2856.
26. Huang Y, Jin X, Zhang X, Sun H, Tu J, Tang T, Chang J, Dai K,. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 2009; 30: 5041-5048.
27. Rungseevijitprapa W, Bodmeier R,. Injectability of biodegradable in situ forming microparticle systems (ISM). Eur J Pharm Sci 2009; 36: 524-531.
28. Heidemann W, Jeschkeit-Schubbert S, Ruffieux K, Fischer JH, Jung H, Krueger G, Wintermantel E, Gerlach KL,. pH-stabilization of predegraded PDLLA by an admixture of water-soluble sodiumhydrogenphosphate-Results of an in vitro- and in vivo-study. Biomaterials 2002; 23: 3567-3574. (Pubitemid 34626560)
29. Ara M, Watanabe M, Imai Y,. Effect of blending calcium compounds on hydrolytic degradation of poly(DL -lactic acid-co-glycolic acid). Biomaterials 2002; 23: 2479-2483. (Pubitemid 34288489)
30. Verrier S, Blaker JJ, Maquet V, Hench LL, Boccaccini AR,. PDLLA/bioglass composites for soft-tissue and hard-tissue engineering: An in vitro cell biology assessment. Biomaterials 2004; 25: 3013-3021. (Pubitemid 38213148)
31. Liu X, Ding C, Chu PK,. Mechanism of apatite formation on wollastonite coatings in simulated body fluids. Biomaterials 2004; 25: 1755-1761. (Pubitemid 38102251)
32. 3 ceramics on their physical and biological properties. Biomaterials 2007; 28: 3171-3181. (Pubitemid 46661856)
33. Wu C, Ramaswamy Y, Chang J, Woods J, Chen Y, Zreiqat H,. The effect of Zn contents on phase composition, chemical stability and cellular bioactivity in Zn-Ca-Si system ceramics. J Biomed Mater Res B Appl Biomater 2008; 87: 346-353.
34. Wu C, Chang J,. Degradation, bioactivity, and cytocompatibility of diopside, akermanite, and bredigite ceramics. J Biomed Mater Res B Appl Biomater 2007; 83: 153-160. (Pubitemid 47463209)
35. El-Ghannam A, Ducheyne P, Shapiro IM,. Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix. Biomaterials 1997; 18: 295-303. (Pubitemid 27073049)
36. Wu C, Chang J, Ni S, Wang J,. In vitro bioactivity of akermanite ceramics. J Biomed Mater Res A 2006; 76: 73-80. (Pubitemid 43075683)
37. Wu C, Xiao Y,. Evaluation of the in vitro bioactivity of bioceramics. Bone Tissue Regeneration Insights 2009; 2: 25-29.
38. Pan H, Zhao X, Darvell BW, Lu WW,. Apatite-formation ability-Predictor of "bioactivity"? Acta Biomater 2010; 6: 4181-4188.